Considering the less than sufficient sample size for the pooled analysis of leukemia and the potential genetic relationship between mTOR gene expression and the rs2295080 polymorphism, relevant population-based clinical investigations by clinicians and researchers are warranted. The gene discussed is MTOR; the disease is leukemia.